HUTCHMED Insider Holds 16,000 Shares Amid Tazverik Recall, Signals Confidence for Future Growth
Insider holdings at HUTCHMED China reveal director confidence amid a Tazverik recall and a strong Phase II/III pipeline, indicating resilience and long‑term upside.
4 minutes to read